292 related articles for article (PubMed ID: 31489145)
1. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells.
Dusoswa SA; Horrevorts SK; Ambrosini M; Kalay H; Paauw NJ; Nieuwland R; Pegtel MD; Würdinger T; Van Kooyk Y; Garcia-Vallejo JJ
J Extracell Vesicles; 2019; 8(1):1648995. PubMed ID: 31489145
[TBL] [Abstract][Full Text] [Related]
2. Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination.
Horrevorts SK; Stolk DA; van de Ven R; Hulst M; van Het Hof B; Duinkerken S; Heineke MH; Ma W; Dusoswa SA; Nieuwland R; Garcia-Vallejo JJ; van de Loosdrecht AA; de Gruijl TD; van Vliet SJ; van Kooyk Y
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31466401
[TBL] [Abstract][Full Text] [Related]
3. Life stage-specific glycosylation of extracellular vesicles from
Kuipers ME; Nguyen DL; van Diepen A; Mes L; Bos E; Koning RI; Nolte-'t Hoen ENM; Smits HH; Hokke CH
Front Mol Biosci; 2023; 10():1125438. PubMed ID: 37006612
[TBL] [Abstract][Full Text] [Related]
4. DC-SIGN mediated internalisation of glycosylated extracellular vesicles from
Kuipers ME; Nolte-'t Hoen ENM; van der Ham AJ; Ozir-Fazalalikhan A; Nguyen DL; de Korne CM; Koning RI; Tomes JJ; Hoffmann KF; Smits HH; Hokke CH
J Extracell Vesicles; 2020; 9(1):1753420. PubMed ID: 32489529
[TBL] [Abstract][Full Text] [Related]
5. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
6. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
[TBL] [Abstract][Full Text] [Related]
7. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
[TBL] [Abstract][Full Text] [Related]
9. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
11. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
[TBL] [Abstract][Full Text] [Related]
12. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific targeting of extracellular vesicles through engineering the glycocalyx.
Zheng W; He R; Liang X; Roudi S; Bost J; Coly PM; van Niel G; Andaloussi SEL
J Extracell Vesicles; 2022 Dec; 11(12):e12290. PubMed ID: 36463392
[TBL] [Abstract][Full Text] [Related]
14. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
[TBL] [Abstract][Full Text] [Related]
15. A Lectin-EGF antibody promotes regulatory T cells and attenuates nephrotoxic nephritis via DC-SIGN on dendritic cells.
Cai M; Wu J; Mao C; Ren J; Li P; Li X; Zhong J; Xu C; Zhou T
J Transl Med; 2013 Apr; 11():103. PubMed ID: 23627732
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells.
Hsu SC; Chen CH; Tsai SH; Kawasaki H; Hung CH; Chu YT; Chang HW; Zhou Y; Fu J; Plunkett B; Su SN; Vieths S; Lee RT; Lee YC; Huang SK
J Biol Chem; 2010 Mar; 285(11):7903-10. PubMed ID: 20080962
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes.
Colmenares M; Puig-Kröger A; Pello OM; Corbí AL; Rivas L
J Biol Chem; 2002 Sep; 277(39):36766-9. PubMed ID: 12122001
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas.
Nonaka M; Ma BY; Imaeda H; Kawabe K; Kawasaki N; Hodohara K; Kawasaki N; Andoh A; Fujiyama Y; Kawasaki T
J Biol Chem; 2011 Jun; 286(25):22403-13. PubMed ID: 21515679
[TBL] [Abstract][Full Text] [Related]
19. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.
van Montfort T; Eggink D; Boot M; Tuen M; Hioe CE; Berkhout B; Sanders RW
J Immunol; 2011 Nov; 187(9):4676-85. PubMed ID: 21957147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
